US › Healthcare

Astrana Health Inc (ASTH)

US · Healthcare · Medical Care Facilities

$35.67-0.67%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$965.1M
Revenue YoY
+55.6%
Net profit
$14.4M
Profit YoY
+115.7%
EPS
$0.74
EPS estimate
$0.65
Net margin
1.5%

EPS came in at 0.74 against a street estimate of 0.65 — a beat of 13.8%.

Key statistics

Market cap
$1.78B
P/E
58.9
Forward P/E
23.0
P/B
2.20
Book value
$16.35
EPS (TTM)
$0.61
52-week high
$51.60
52-week low
$18.08
50-day MA
$41.39
200-day MA
$30.38
Beta
0.90

Analyst view

Analysts rate Astrana Health Inc a strong buy (9 buy, 3 hold, 0 sell out of 12) with an average price target of $49.33.

Shareholding

Insiders
22.87%
Institutions
61.51%

Largest institutional holders

FundStake
BlackRock Inc12.43%
Vanguard Group Inc8.55%
Vanguard Portfolio Management, LLC4.59%
325 Capital LLC3.71%
Vanguard Capital Management, LLC3.45%
State Street Corp3.33%
Dimensional Fund Advisors, Inc.2.76%
Wellington Management Company LLP2.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Astrana Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.